Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
Se Jun ParkHyun Ho KimKabsoo ShinTae Ho HongJa Hee SuhMyung Ah LeePublished in: BMC cancer (2021)
Retrospectively registered.
Keyphrases